Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is arduous and uptake is low, but new highly effective and t...

Full description

Saved in:
Bibliographic Details
Main Authors: Martin, Natasha K, Vickerman, Peter, Grebely, Jason, Hellard, Margaret, Hutchinson, Sharon J, Lima, Viviane D, Foster, Graham R, Dillon, John F, Goldberg, David J, Dore, Gregory J, Hickman, Matthew
Format: Artigo
Language:Inglês
Published: Blackwell publishing Ltd 2013
Subjects:
Viral Hepatitis
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3933734/
https://ncbi.nlm.nih.gov/pubmed/23553643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.26431
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items